REG - Chesnara PLC - Total Voting Rights

ChesnaraAnnouncement

29/05/2020 07:01

RNS Number : 2581O
  
Chesnara PLC
  
29 May 2020
  
 

CHESNARA plc 
("Chesnara" or "the Company")
 
LEI Number: 213800VFRMBRTSZ3SJ06
29 May 2020
TOTAL VOTING RIGHTS
 
In conformity with 5.6.1 of the Disclosure Guidance and Transparency Rules, the Company notifies the market of the following: -
 
The Company's issued share capital as at the date of this announcement consisted of 150,065,457 ordinary 5p shares and, with no shares in Treasury, this too was the number of voting rights.
 
This figure of 150,065,457 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
 
 
For further information, please contact: 
 
Roddy Watt
Director, Capital Markets
FWD
Forward thinking communications
 
T   -    020 7280 0651   
E   -    roddy.watt@fwdconsulting.co.uk 
 
 
Notes to Editors
Chesnara is a life and pensions company listed on the London Stock Exchange.  It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
 
Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.
 
Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 15 years in succession.
 
Further details are available on the Company's website (www.chesnara.co.uk).


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
TVRUWAORRUUVUAR